{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:12Z","timestamp":1786995612141,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021515","name":"Sanofi Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001786","name":"University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["10066835"],"award-info":[{"award-number":["10066835"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1147333"],"award-info":[{"award-number":["1147333"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.peptides.2023.171092","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T18:39:17Z","timestamp":1693852757000},"page":"171092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Serum alanine transaminase is predictive of fasting and postprandial insulin and glucagon concentrations in type 2 diabetes"],"prefix":"10.1016","volume":"169","author":[{"given":"Weikun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai J.","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1656-9210","authenticated-orcid":false,"given":"Tongzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.peptides.2023.171092_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.peptides.2023.171092_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1042\/BSR20160385","article-title":"Liver glucose metabolism in humans","volume":"36","author":"Adeva-Andany","year":"2016","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.peptides.2023.171092_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/diacare.3.2.261","article-title":"Role of liver in glucose homeostasis","volume":"3","author":"Sherwin","year":"1980","journal-title":"Diabetes care"},{"issue":"6","key":"10.1016\/j.peptides.2023.171092_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/diab.34.6.580","article-title":"The disposal of an oral glucose load in healthy subjects: a quantitative study","volume":"34","author":"Ferrannini","year":"1985","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.peptides.2023.171092_bib5","first-page":"682","article-title":"Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study","volume":"44","author":"Iozzo","year":"2003","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.peptides.2023.171092_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI108649","article-title":"Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man","volume":"59","author":"Liljenquist","year":"1977","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2023.171092_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1463-1326.2011.01454.x","article-title":"Physiologic action of glucagon on liver glucose metabolism","volume":"13","author":"Ramnanan","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.peptides.2023.171092_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1463-1326.2011.01449.x","article-title":"The role of dysregulated glucagon secretion in type 2 diabetes","volume":"13","author":"D'alessio","year":"2011","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.peptides.2023.171092_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41580-020-00317-7","article-title":"Mechanisms controlling pancreatic islet cell function in insulin secretion","volume":"22","author":"Campbell","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.peptides.2023.171092_bib10","first-page":"30","article-title":"What is the real function of the liver \u2018function\u2019tests?","volume":"81","author":"Hall","year":"2012","journal-title":"Ulst. Med. J."},{"issue":"1","key":"10.1016\/j.peptides.2023.171092_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/SLA.0b013e31825d5d47","article-title":"Physiological and biochemical basis of clinical liver function tests: a review","volume":"257","author":"Hoekstra","year":"2013","journal-title":"Ann. Surg."},{"issue":"17","key":"10.1016\/j.peptides.2023.171092_bib12","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.peptides.2023.171092_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"Cmaj"},{"issue":"932","key":"10.1016\/j.peptides.2023.171092_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/pmj.79.932.307","article-title":"Evaluation of abnormal liver function tests","volume":"79","author":"Limdi","year":"2003","journal-title":"Postgrad. Med. J."},{"issue":"4","key":"10.1016\/j.peptides.2023.171092_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02042814","article-title":"Two-hour glucose and insulin responses after a standardized oral glucose load in relation to serum gamma-glutamyl transferase and alcohol consumption","volume":"18","author":"Trell","year":"1981","journal-title":"Acta Diabetol. Lat."},{"issue":"5","key":"10.1016\/j.peptides.2023.171092_bib16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2337\/diacare.21.5.732","article-title":"Prospective study of serum \u03b3-glutamyltransferase and risk of NIDDM","volume":"21","author":"Perry","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2023.171092_bib17","first-page":"EJ20","article-title":"Prediction of new onset of diabetes mellitus during a 10-year period by using a combination of levels of alanine aminotransferase and \u03b3-glutamyl transferase","author":"Miyamori","year":"2021","journal-title":"Endocr. J."},{"issue":"4","key":"10.1016\/j.peptides.2023.171092_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/dc08-1870","article-title":"Alanine aminotransferase, \u03b3-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis","volume":"32","author":"Fraser","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2023.171092_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/IJGM.S332946","article-title":"ALT\/AST as an independent risk factor of gestational diabetes mellitus compared with TG\/HDL-C","volume":"15","author":"Song","year":"2022","journal-title":"Int. J. Gen. Med."},{"issue":"6","key":"10.1016\/j.peptides.2023.171092_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2337\/diabetes.51.6.1889","article-title":"High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.peptides.2023.171092_bib21","first-page":"1","article-title":"Liver fat, hepatic enzymes, alkaline phosphatase and the risk of incident type 2 diabetes: a prospective study of 132,377 adults","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.peptides.2023.171092_bib22","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.2337\/diacare.28.12.2913","article-title":"Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men","volume":"28","author":"Wannamethee","year":"2005","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.peptides.2023.171092_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.numecd.2011.02.002","article-title":"One-hour post-load plasma glucose levels are associated with elevated liver enzymes","volume":"21","author":"Succurro","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.peptides.2023.171092_bib24","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/db10-1806","article-title":"Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women","volume":"60","author":"Bonnet","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.peptides.2023.171092_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.peptides.2023.171092_bib26","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/dc20-0190","article-title":"Effects of sustained treatment with lixisenatide on gastric emptying and postprandial glucose metabolism in type 2 diabetes: a randomized controlled trial","volume":"43","author":"Rayner","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.peptides.2023.171092_bib27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/dom.13633","article-title":"Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes","volume":"21","author":"Jones","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.peptides.2023.171092_bib28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/dom.13604","article-title":"A whey\/guar \u201cpreload\u201d improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: a 12\u2013week, single\u2010blind, randomized, placebo\u2010controlled trial.","volume":"21","author":"Watson","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.peptides.2023.171092_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2337\/dc15-2298","article-title":"A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes","volume":"39","author":"Wu","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.peptides.2023.171092_bib30","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/dom.14673","article-title":"Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit","volume":"24","author":"Wu","year":"2022","journal-title":"Diabetes, Obes. Metab."},{"issue":"3","key":"10.1016\/j.peptides.2023.171092_bib31","doi-asserted-by":"crossref","first-page":"E849","DOI":"10.1152\/ajpendo.00289.2007","article-title":"Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans","volume":"293","author":"Meier","year":"2007","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.peptides.2023.171092_bib32","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.peptides.2023.171092_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2023.171092_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.170941","article-title":"The \u2018early\u2019 postprandial glucagon response is related to the rate of gastric emptying in patients with type 2 diabetes","author":"Huang","year":"2023","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.peptides.2023.171092_bib35","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/db10-1806","article-title":"Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women","volume":"60","author":"Bonnet","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.peptides.2023.171092_bib36","doi-asserted-by":"crossref","first-page":"G91","DOI":"10.1152\/ajpgi.00216.2017","article-title":"Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes","volume":"314","author":"Wewer Albrechtsen","year":"2018","journal-title":"Am. J. Physiol. - Gastrointest. Liver Physiol."},{"issue":"11","key":"10.1016\/j.peptides.2023.171092_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJMoa012578","article-title":"Prevalence of impaired glucose tolerance among children and adolescents with marked obesity","volume":"346","author":"Sinha","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.peptides.2023.171092_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/diacare.14.4.271","article-title":"Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians","volume":"14","author":"Dowse","year":"1991","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.peptides.2023.171092_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/dc11-1853","article-title":"Combined influence of insulin resistance, overweight\/obesity, and fatty liver as risk factors for type 2 diabetes","volume":"35","author":"Sung","year":"2012","journal-title":"Diabetes care"},{"issue":"8","key":"10.1016\/j.peptides.2023.171092_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.peptides.2023.171092_bib41","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2337\/dbi22-0004","article-title":"The liver\u2013\u03b1-cell axis in health and in disease","volume":"71","author":"Richter","year":"2022","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.peptides.2023.171092_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00125-017-4535-5","article-title":"Evidence of a liver\u2013alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids","volume":"61","author":"Wewer Albrechtsen","year":"2018","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.peptides.2023.171092_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978123001572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978123001572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:47:20Z","timestamp":1778676440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978123001572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":43,"alternative-id":["S0196978123001572"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2023.171092","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum alanine transaminase is predictive of fasting and postprandial insulin and glucagon concentrations in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2023.171092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"171092"}}